Clinical Trials Directory

Trials / Completed

CompletedNCT04247828

Adaptive and Individualized AAC

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Altec Inc. · Industry
Sex
All
Age
12 Years
Healthy volunteers
Accepted

Summary

This project will test the feasibility of developing a smart augmentative or alternative communication (AAC) system that is effective in delivering communication capabilities that automatically adapt to the users' physical abilities.

Detailed description

The diversity of the more than 1.3% of Americans who suffer from severe physical impairments (SPIs) preclude the use of common augmentative or alternative communication (AAC) solutions such as manual signs, gestures or interaction with a touchscreen for communication. This clinical trial will test the feasibility of developing a smart-AAC system designed using individually adaptive access methods and AAC interfaces to accommodate the unique manifestations of motor impairments specific to each user. The investigators will demonstrate the proof-of-concept that a single surface electromyographic (sEMG) and inertial measurement unit (IMU) hybrid sensor worn on the forehead can provide improvements in information transfer rate (ITR) and communication accuracy when integrated with an AAC interface that is optimized compared to a conventional (non-adaptable) interface for subjects with SPI.

Conditions

Interventions

TypeNameDescription
DEVICEExperimental AACParticipant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with an adaptive and individualized keyboard to test communication performance.
DEVICEGeneric AACParticipant receives an AAC system comprising a single hybrid wearable sensor for head-mediated cursor control that is integrated with a generic QWERTY keyboard to test communication performance.

Timeline

Start date
2020-01-06
Primary completion
2021-08-31
Completion
2021-08-31
First posted
2020-01-30
Last updated
2022-04-06
Results posted
2022-04-06

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04247828. Inclusion in this directory is not an endorsement.